Optimer Pharmaceuticals Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 281

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $551M

  • Investors
  • 1

Optimer Pharmaceuticals General Information

Description

Operator of a biopharmaceutical company focused on developing and commercializing hospital specialty products that have a positive impact on society and provide value for the healthcare system. The company developed an antibacterial drug for the treatment of Clostridium difficile-associated diarrhea (CDAD), thereby focusing on medicines that make a significant difference in the lives of patients and reduce the burden of disease.

Contact Information

Website
www.optimerpharma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 101 Hudson Street
  • Suite 3501
  • Jersey City, NJ 07302
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Cubist Pharmaceuticals
Corporate Office
  • 101 Hudson Street
  • Suite 3501
  • Jersey City, NJ 07302
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Optimer Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 24-Oct-2013 $551M Completed Generating Revenue
8. 2PO 16-Feb-2011 Completed Generating Revenue
7. 2PO 01-Mar-2010 Completed Generating Revenue
6. 2PO 09-Mar-2009 Completed Generating Revenue
5. IPO 09-Feb-2007 Completed Generating Revenue
4. Later Stage VC (Series D) 30-Nov-2005 Completed Generating Revenue
3. Later Stage VC (Series C) 29-Apr-2005 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Dec-2001 $32.1M $35.5M Completed Generating Revenue
1. Early Stage VC (Series A) 01-May-2000 $3.4M $3.4M Completed Generating Revenue
To view Optimer Pharmaceuticals’s complete valuation and funding history, request access »

Optimer Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Optimer Pharmaceuticals Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
BB Biotech Ventures Venture Capital Minority
CDIB Capital Group Asset Manager Minority
E. Sun FHC Corporation Minority
Formosa Healthcare Investments Corporation Minority
Fubon Financial Holding Holding Company Minority
You’re viewing 5 of 15 investors. Get the full list »

Optimer Pharmaceuticals Investments (1)

Optimer Pharmaceuticals’s most recent deal was a Early Stage VC with Cempra Pharmaceuticals for . The deal was made on 14-Dec-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cempra Pharmaceuticals 14-Dec-2007 Early Stage VC Pharmaceuticals
To view Optimer Pharmaceuticals’s complete investments history, request access »

Ready to get started?

Request a free trial

Optimer Pharmaceuticals FAQs

  • When was Optimer Pharmaceuticals founded?

    Optimer Pharmaceuticals was founded in 1998.

  • Where is Optimer Pharmaceuticals headquartered?

    Optimer Pharmaceuticals is headquartered in Jersey City, NJ.

  • What is the size of Optimer Pharmaceuticals?

    Optimer Pharmaceuticals has 281 total employees.

  • What industry is Optimer Pharmaceuticals in?

    Optimer Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Optimer Pharmaceuticals a private or public company?

    Optimer Pharmaceuticals is a Private company.

  • What is the current valuation of Optimer Pharmaceuticals?

    The current valuation of Optimer Pharmaceuticals is .

  • What is Optimer Pharmaceuticals’s current revenue?

    The current revenue for Optimer Pharmaceuticals is .

  • How much funding has Optimer Pharmaceuticals raised over time?

    Optimer Pharmaceuticals has raised $277M.

  • Who are Optimer Pharmaceuticals’s investors?

    BB Biotech Ventures, CDIB Capital Group, E. Sun FHC, Formosa Healthcare Investments, and Fubon Financial Holding are 5 of 15 investors who have invested in Optimer Pharmaceuticals.

  • When was Optimer Pharmaceuticals acquired?

    Optimer Pharmaceuticals was acquired on 24-Oct-2013.

  • Who acquired Optimer Pharmaceuticals?

    Optimer Pharmaceuticals was acquired by Cubist Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process